Similarly, paclitaxel-sensitive NPC cells have been reported to deliver miR-183-5p to paclitaxel-resistant NPC cells via EVs, thereby suppressing paclitaxel resistance by negatively regulating ABCB1[112]. Here, ABCB1 is linked to nasopharyngeal carcinoma.